Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report

Keigo Kobayashi, Ichiro Nakachi, Akifumi Mitsuishi, Daisuke Arai, Kaori Sakurai, Katsunori Masaki, Atsushi Chiyotani, Hidenori Takahashi, Toshiyuki Tahara, Kenzo Soejima

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e30-e32
JournalClinical Lung Cancer
Volume21
Issue number1
DOIs
Publication statusPublished - 2020 Jan

Keywords

  • Immune-related adverse events
  • Immunotherapy
  • NSCLC
  • PD-1 inhibitors
  • Severe hepatitis

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this